These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30617096)

  • 1. Investigation of Novel
    Gerson S; Betts JW; Lucaßen K; Nodari CS; Wille J; Josten M; Göttig S; Nowak J; Stefanik D; Roca I; Vila J; Cisneros JM; La Ragione RM; Seifert H; Higgins PG
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
    Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
    Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
    Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin.
    Potron A; Vuillemenot JB; Puja H; Triponney P; Bour M; Valot B; Amara M; Cavalié L; Bernard C; Parmeland L; Reibel F; Larrouy-Maumus G; Dortet L; Bonnin RA; Plésiat P
    J Antimicrob Chemother; 2019 Sep; 74(9):2544-2550. PubMed ID: 31199431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and virulence characterization of colistin-resistant and colistin-sensitive A. baumannii clinical isolates.
    Leite GC; Stabler RA; Neves P; Perdigão Neto LV; Ruedas Martins RC; Rizek C; Rossi F; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):99-101. PubMed ID: 31178071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant
    Vijayakumar S; Swetha RG; Bakthavatchalam YD; Vasudevan K; Abirami Shankar B; Kirubananthan A; Walia K; Ramaiah S; Biswas I; Veeraraghavan B; Anbarasu A
    Microbiol Spectr; 2024 Feb; 12(2):e0251123. PubMed ID: 38214512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
    Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.
    Charretier Y; Diene SM; Baud D; Chatellier S; Santiago-Allexant E; van Belkum A; Guigon G; Schrenzel J
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoters of Colistin Resistance in
    Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
    Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
    [No Abstract]   [Full Text] [Related]  

  • 15. PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
    Lunha K; Thet KT; Ngudsuntia A; Charoensri N; Lulitanond A; Tavichakorntrakool R; Wonglakorn L; Faksri K; Chanawong A
    Infect Genet Evol; 2020 Nov; 85():104577. PubMed ID: 33007498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
    Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates.
    El Mrimar N; Belouad EM; Benaissa E; Bssaibis F; Jazouli M; El Alaoui MA; Maleb A; Elouennass M
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):134-139. PubMed ID: 38837239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii.
    Park YK; Choi JY; Shin D; Ko KS
    Int J Antimicrob Agents; 2011 Jun; 37(6):525-30. PubMed ID: 21497062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.
    Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R
    Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment.
    Kim Y; Bae IK; Lee H; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):362-6. PubMed ID: 24809861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.